The Influence of Endotracheal Tube Design on Fluid Leakage Into the Lungs During Surgery
Primary Purpose
Respiratory Aspiration
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Methylene Blue
Sponsored by
About this trial
This is an interventional prevention trial for Respiratory Aspiration focused on measuring Aspiration, Respiratory
Eligibility Criteria
Inclusion Criteria:
- Male or Female of all races
- Older than 18 years old
- Scheduled for an elective surgical procedure under general anesthesia for no less than 2hr and no more than 12hr with planned endotracheal intubation via the oral route
- Willing and able to give informed consent for participation in the study
- Anticipated extubation at the conclusion of general anesthesia in the operating room and prior to admission to the PACU
- Expected hospital stay of greater than or equal to 23hrs
Exclusion Criteria:
- Preexisting acute respiratory illness requiring antibiotic treatment within the two weeks prior to surgery
- Temperature of over 101 degrees F (38.3 C) at time of scheduled surgery
- Surgical requirement for naso-tracheal intubation
- Patients undergoing surgical procedures directly on the lungs, trachea, or airways
- Presence of tracheostomy
- History of allergic reaction to methylene blue
- Methemoglobinemia, glucose-6-phosphate (G6PD) deficiency
- Renal insufficiency or failure
- Requirement for prolonged intubation and/or ventilation beyond the point of PACU admission
- Intraoperative use of nitrous oxide, to avoid the increase in cuff pressure due to diffusion of gas over time
- Psychiatric drugs of the following classifications: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs).
- Patients younger than 18 years of age
- Prone positioning during surgery
- Pregnant or lactating women based on standardized preoperative screening protocols
- Legally detained prisoner status
- Unwilling or unable to give informed consent for participation in the study
Sites / Locations
- Tulane University Hospital and Clinics
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Hi-Lo endotracheal tube
TaperGuard endotracheal tube
Arm Description
Hi-Lo endotracheal tube with barrel shaped cuff with 20 cc of methylene blue instilled above the cuff once post intubation for the duration of the surgical procedure
TaperGuard endotracheal tube with taper shaped cuff with 20 cc methylene blue instilled above the cuff once post intubation for the duration of the surgical procedure
Outcomes
Primary Outcome Measures
Number of Participants With Dye Leakage
Blue dye will be instilled above the endotracheal tube cuff immediately after intubation where it will remain for the duration of the surgery. The presence of dye leakage past the endotracheal tube cuff will be determined via analysis of bronchoscopic images taken at the end of the surgical procedure when surgical closure has begun.
Secondary Outcome Measures
Length of Hospital Stay
Time of readiness for discharge from PACU, defined as when an Aldrete score of greater than or equal to 8 is given, to the time at which discharge (from the hospital) orders are written. The inpatient period may extend up to 72 hours.
Number of Participants With Postoperative Pneumonia
Diagnosis of postoperative pneumonia during the 30 day follow up period after surgery
Number of Participants With Unanticipated Intensive Care Unit Admission
Incidence of unscheduled Intensive Care Unit admission after surgery and length of ICU stay if applicable.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01539135
Brief Title
The Influence of Endotracheal Tube Design on Fluid Leakage Into the Lungs During Surgery
Official Title
The Influence of Endotracheal Tube Cuff Design on Intraoperative Microaspiration and Postoperative Respiratory Complications
Study Type
Interventional
2. Study Status
Record Verification Date
August 2015
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
May 2013 (Actual)
Study Completion Date
May 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medtronic - MITG
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Surgical patients have an endotracheal tube inserted into their windpipe to help them breathe while under general anesthesia. These tubes have a "cuff" on the outside that is inflated in the trachea to help prevent fluids from leaking into the lungs. These cuffs come in different shapes and sizes. The TaperGuard endotracheal tube has a taper-shaped cuff that has been shown in animals to decrease the leakage of fluid past the cuff better than a traditional tube that has a barrel-shaped cuff. This study is designed to examine whether the use of the TaperGuard tube during surgery on humans decreases the amount of leakage past the cuff to a greater degree than the traditional barrel-shaped cuff. In addition, the study will investigate whether the use of the TaperGuard tube is associated with a decrease in respiratory complications often seen following surgery which may be related to fluid leaking past the cuff and into the lungs. It is thought that the use of the TaperGuard endotracheal tube will result in a decrease in fluid leakage past the cuff and that it will be associated with a decrease in respiratory complications during the 30 days after surgery.
Detailed Description
This study is designed to yield data on the intraoperative use of TaperGuard™endotracheal tubes and its potential influence on postoperative pulmonary complications and outcomes. The TaperGuard Basic tube has a taper-shaped cuff and has been shown, via bench and animal testing, to decrease microaspiration, which has been associated with respiratory difficulties. The intraoperative use of this tube (i.e. during short term intubation), and its impact on postoperative complications and outcomes has not been investigated. This study will determine whether the intraoperative use of the TaperGuard tube results in a decrease in microaspiration compared to the Hi-Lo endotracheal tube having a barrel-shaped cuff. Moreover, the relationship between a decrease in microaspiration and subsequent decrease in postoperative respiratory complications will be explored.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Aspiration
Keywords
Aspiration, Respiratory
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Hi-Lo endotracheal tube
Arm Type
Active Comparator
Arm Description
Hi-Lo endotracheal tube with barrel shaped cuff with 20 cc of methylene blue instilled above the cuff once post intubation for the duration of the surgical procedure
Arm Title
TaperGuard endotracheal tube
Arm Type
Experimental
Arm Description
TaperGuard endotracheal tube with taper shaped cuff with 20 cc methylene blue instilled above the cuff once post intubation for the duration of the surgical procedure
Intervention Type
Drug
Intervention Name(s)
Methylene Blue
Other Intervention Name(s)
Methylene Blue Dye
Intervention Description
20 cc methylene blue instilled above the cuff once after intubation for the duration of the surgical procedure
Primary Outcome Measure Information:
Title
Number of Participants With Dye Leakage
Description
Blue dye will be instilled above the endotracheal tube cuff immediately after intubation where it will remain for the duration of the surgery. The presence of dye leakage past the endotracheal tube cuff will be determined via analysis of bronchoscopic images taken at the end of the surgical procedure when surgical closure has begun.
Time Frame
Duration of surgical procedure - from 2 to 12 hours
Secondary Outcome Measure Information:
Title
Length of Hospital Stay
Description
Time of readiness for discharge from PACU, defined as when an Aldrete score of greater than or equal to 8 is given, to the time at which discharge (from the hospital) orders are written. The inpatient period may extend up to 72 hours.
Time Frame
Time from discharge from PACU to discharge from hospital up to 72 hours
Title
Number of Participants With Postoperative Pneumonia
Description
Diagnosis of postoperative pneumonia during the 30 day follow up period after surgery
Time Frame
Up to 30 days after surgery
Title
Number of Participants With Unanticipated Intensive Care Unit Admission
Description
Incidence of unscheduled Intensive Care Unit admission after surgery and length of ICU stay if applicable.
Time Frame
Time from discharge from PACU to discharge from hospital up to 72 hours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or Female of all races
Older than 18 years old
Scheduled for an elective surgical procedure under general anesthesia for no less than 2hr and no more than 12hr with planned endotracheal intubation via the oral route
Willing and able to give informed consent for participation in the study
Anticipated extubation at the conclusion of general anesthesia in the operating room and prior to admission to the PACU
Expected hospital stay of greater than or equal to 23hrs
Exclusion Criteria:
Preexisting acute respiratory illness requiring antibiotic treatment within the two weeks prior to surgery
Temperature of over 101 degrees F (38.3 C) at time of scheduled surgery
Surgical requirement for naso-tracheal intubation
Patients undergoing surgical procedures directly on the lungs, trachea, or airways
Presence of tracheostomy
History of allergic reaction to methylene blue
Methemoglobinemia, glucose-6-phosphate (G6PD) deficiency
Renal insufficiency or failure
Requirement for prolonged intubation and/or ventilation beyond the point of PACU admission
Intraoperative use of nitrous oxide, to avoid the increase in cuff pressure due to diffusion of gas over time
Psychiatric drugs of the following classifications: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs).
Patients younger than 18 years of age
Prone positioning during surgery
Pregnant or lactating women based on standardized preoperative screening protocols
Legally detained prisoner status
Unwilling or unable to give informed consent for participation in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sabrina Bent, MD
Organizational Affiliation
Tulane University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tulane University Hospital and Clinics
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70112
Country
United States
12. IPD Sharing Statement
Learn more about this trial
The Influence of Endotracheal Tube Design on Fluid Leakage Into the Lungs During Surgery
We'll reach out to this number within 24 hrs